Gagnon Securities LLC
- SEC CIK
- 0001125725
- Latest filing
- Aug 4, 2026
DRRX holding history
Durect Corp in every 13F filed by Gagnon Securities LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DRRX overviewAll 13F holders of DRRXFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 18
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −403,884−100.0% | Sold out | Holders |
| Q2 2025 | 403,884 | $256.5K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 403,884 | $323.9K | 0.1% | +1,871+0.5% | Added | Holders |
| Q4 2024 | 402,013 | $301.5K | 0.1% | +8,151+2.1% | Added | Holders |
| Q3 2024 | 393,862 | $527.8K | 0.1% | +19,648+5.3% | Added | Holders |
| Q2 2024 | 374,214 | $482.7K | 0.1% | −5,917−1.6% | Reduced | Holders |
| Q1 2024 | 380,131 | $460.0K | 0.1% | +21,425+6.0% | Added | Holders |
| Q4 2023 | 358,706 | $211.6K | 0.1% | +101,938+39.7% | Added | Holders |
| Q3 2023 | 256,768 | $639.4K | 0.2% | +66,354+34.8% | Added | Holders |
| Q2 2023 | 190,414 | $942.5K | 0.2% | +20,815+12.3% | Added | Holders |
| Q1 2023 | 169,599 | $768.3K | 0.2% | +13,792+8.9% | Added | Holders |
| Q4 2022 | 155,807 | $539.1K | 0.1% | +7,765+5.2% | AddedConverted for a 1-for-10 split | Holders |
| Q3 2022 | 1,480,419 | $856.0K | 0.2% | +1,200+0.1% | Added | Holders |
| Q2 2022 | 1,479,219 | $707.0K | 0.1% | +25,000+1.7% | Added | Holders |
| Q1 2022 | 1,454,219 | $974.0K | 0.2% | +53,168+3.8% | Added | Holders |
| Q4 2021 | 1,401,051 | $1.38M | 0.2% | +73,647+5.5% | Added | Holders |
| Q3 2021 | 1,327,404 | $1.70M | 0.3% | −903−0.1% | Reduced | Holders |
| Q2 2021 | 1,328,307 | $2.17M | 0.3% | −15,498−1.2% | Reduced | Holders |
| Q1 2021 | 1,343,805 | $2.66M | 0.4% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.